All terms in MESH
| Label | Id | Description |
|---|---|---|
| Urinary Retention | D016055 | [Inability to empty the URINARY BLADDER with voiding (URINATION).] |
| Urination Disorders | D014555 | [Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.] |
| Immunodominant Epitopes | D016056 | [Subunits of the antigenic determinant that are most easily recognized by the immune system and thus most influence the specificity of the induced antibody.] |
| Epitopes | D000939 | [Sites on an antigen that interact with specific antibodies.] |
| Evoked Potentials, Auditory, Brain Stem | D016057 | [Electrical waves in the CEREBRAL CORTEX generated by BRAIN STEM structures in response to auditory click stimuli. These are found to be abnormal in many patients with CEREBELLOPONTINE ANGLE lesions, MULTIPLE SCLEROSIS, or other DEMYELINATING DISEASES.] |
| Evoked Potentials, Auditory | D005072 | [The electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS.] |
| Analgesia, Patient-Controlled | D016058 | [Relief of PAIN, without loss of CONSCIOUSNESS, through ANALGESIC AGENTS administered by the patients. It has been used successfully to control POSTOPERATIVE PAIN, during OBSTETRIC LABOR, after BURNS, and in TERMINAL CARE. The choice of agent, dose, and lockout interval greatly influence effectiveness. The potential for overdose can be minimized by combining small bolus doses with a mandatory interval between successive doses (lockout interval).] |
| Analgesia | D000698 | [Methods of PAIN relief that may be used with or in place of ANALGESICS.] |
| Range of Motion, Articular | D016059 | [The distance and direction to which a bone joint can be extended. Range of motion is a function of the condition of the joints, muscles, and connective tissues involved. Joint flexibility can be improved through appropriate MUSCLE STRETCHING EXERCISES.] |
| Musculoskeletal Physiological Phenomena | D009142 | [Processes and properties of the MUSCULOSKELETAL SYSTEM.] |
| Epilepsy, Benign Neonatal, 3 | C564274 | |
| Natural Cytotoxicity Triggering Receptor 1 | D055627 | [A 46-kD stimulatory receptor found on resting and activated NATURAL KILLER CELLS. It has specificity for VIRAL HEMAGGLUTININS that are expressed on infected cells.] |
| Receptors, Natural Cytotoxicity Triggering | D055636 | [A subclass of natural killer cell receptors that perform an important role in the recognition of tumor cells by NK CELLS.] |
| Neutrophil Immunodeficiency Syndrome | C564275 | |
| Natural Cytotoxicity Triggering Receptor 3 | D055628 | [A 30 kDa stimulatory receptor found on resting and activated NATURAL KILLER CELLS.] |
| Tropical Calcific Pancreatitis | C564276 | |
| Natural Cytotoxicity Triggering Receptor 2 | D055629 | [A 44-kD stimulatory receptor found on activated NATURAL KILLER CELLS. It has specificity for VIRAL HEMAGGLUTININS that are expressed on infected cells.] |
| Immunodeficiency With Hyper-Igm, Type 4 | C564277 | |
| Synpolydactyly 2 | C564278 | |
| Immune System Phenomena | D055633 | [The characteristic properties and processes involved in IMMUNITY and an organism's immune response.] |